FDA issued a Warning Letter to Aplicare, Inc. on 12/15/2016 as a result of this inspection.
FDA investigators audited the Aplicare - Meriden, CT, United States facility and issued 6 inspectional observations (via FDA 483) on 15 Jan 2016.
Product details
- Category: Human Drugs
- Number of Observations: 6
- Inspection end: 15 Jan 2016
- Location: Meriden, United States
- FEI: 1220701
